New Alzheimer's treatment
Brooks Kenny, Executive Director of WomenAgainstAlzheimer's, joins Q13 News This Morning to discuss the FDA's recent approval of the first new Alzheimer’s treatment in more than two decades.
Brooks Kenny, Executive Director of WomenAgainstAlzheimer's, joins Q13 News This Morning to discuss the FDA's recent approval of the first new Alzheimer’s treatment in more than two decades.